ed

Beryllium radical cation isolated

First Be(I) compounds to be crystallized could open up new main group chemistry




ed

Gilead buys immuno-oncology-focused Forty Seven

The $4.9 billion deal adds a mid-stage cancer drug to the big biotech's pipeline




ed

$8.3 billion allocated for US coronavirus response

Congress opts for open-ended support for federal and local agencies




ed

Julie Zimmerman named editor in chief of <i>Environmental Science and Technology</i>




ed

First in vivo CRISPR gene editing in humans




ed

Ingevity CEO Wilson resigns unexpectedly




ed

Calysta and Adisseo plan fish feed venture in Asia




ed

Beryllium radical cation isolated

First Be(I) compounds to be crystallized could open up new main-group chemistry




ed

Erika Milczek is replacing banned chemicals in consumer products

With Curie Co., the entrepreneur designs alternatives to compounds like parabens that have fallen out of favor with retailers




ed

Naomi Halas on being a scientist: ‘We need to be attracted to the big, hard problems'

Nanotech pioneer aims to pursue grand challenges rather than just write about them




ed

One-pot process converts CO<sub>2</sub> captured from the air into methanol

Scientists use an alkali hydroxide–based system to turn carbon dioxide into a carbon-neutral fuel




ed

Star-shaped particles ferry medicine through the skin's barrier

Titanium-dioxide stars lance the skin with microscopic holes to allow medicine through




ed

New PET probes light up bacteria in deep-seated infections

Microbe-specific tracers could help detect infection without relying on inflammation as a surrogate




ed

Bryan Brooks named editor in chief of <i>Environmental Science and Technology Letters</i>




ed

$8.3 billion allocated for US coronavirus response

Congress opts for open-ended support for federal and local agencies




ed

New PET probes light up bacteria in deep-seated infections

Microbe-specific tracers could help detect infection without relying on inflammation as a surrogate




ed

Thirdhand smoke detected in nonsmoking facility

Tobacco-related compounds probably transported on smokers' clothes and bodies




ed

As telecom demands grow, optical fibers will need to level up

Scientists explore how to revamp the hair-thin silica glass fibers to transmit more and more data




ed

Carolyn Bertozzi awarded 2020 Solvay Prize

Stanford professor honored for her invention of bioorthogonal chemistry




ed

Air quality improvements boosted California's agriculture industry

Lower ozone levels led to higher grape and almond yields-and decarbonizing the state's economy could provide a further boost




ed

A radial setup helps automated synthesis branch out

Reactors arranged around a central switching station gives chemists more options for making molecules remotely




ed

Fluorinated gel grabs PFAS

New material captures greater share of “forever chemicals” from water than other methods




ed

DSM to make biobased Dyneema fiber




ed

Fluorinated gel grabs PFAS

New approach captures greater share of ‘forever chemicals' from water than other methods




ed

PVA-based gel removes dirt from paintings

Large, disordered pores allow the gel to capture soil without damaging pigments




ed

New Zealand invests in wind-powered hydrogen plant




ed

AGC to bolster drug services with MolMed acquisition




ed

2020 Priestley Medalist JoAnne Stubbe digs deep into the details of enzymes

The MIT biochemist's intense focus has helped her solve some of biochemistry's important puzzles




ed

Priestley Medal address 2020: The road less traveled—for love of detection, discovery, and all things radical in nature




ed

Lemos confirmed as chair of the US Chemical Safety Board




ed

Not all US science agencies are prepared for sexual harassment claims

Only NIH, NSF publicize their complaint procedures




ed

Structure of active ribonucleotide reductase solved with cryo-electron microscopy

Long-awaited image of elusive disordered tail helps scientists better understand the enzyme's mechanism




ed

Chloroquine's use to treat COVID-19 is backed by US government, but many questions remain

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far




ed

Emory-discovered antiviral is poised for COVID-19 clinical trials

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans




ed

AlloVir and Baylor to make donor-derived T cell therapies that target coronaviruses




ed

BASF subsidiary trinamiX launches handheld near-infrared spectrometer




ed

Lego bricks for cutting-edge physics and for chemistry education




ed

Wanted: Data to make labs safer

Researchers aim to supply evidence to save lives, persevering through lack of recognition and funding




ed

Elusive phosphorus compound synthesized

Long-sought phosphatetrahedrane could lead to new organophosphorus compounds




ed

Zymergen, Sumitomo launch biobased film for electronics




ed

Eastman donates polyester for medical face shields




ed

Arkema plans to exit intermediate chemical businesses




ed

Novel coronavirus thought to have jumped to humans via pangolins

Trafficked scaly anteaters found to carry coronaviruses related to SARS-CoV-2




ed

Acridine radical acts as a powerful photoreductant

Stable organic radical replaces alkali metals or dissolving metal reductants in certain reactions




ed

Chemistry spotted on more belt buckles and model trains, and fashion-forward work boots




ed

Plastic bag bans rolled back for COVID-19

Regulators are restricting reusable bags over worries they might harbor virus




ed

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease




ed

Engineered enzyme pulls apart PET efficiently

Up to 90% of the popular plastic can be broken into monomers in a matter of hours




ed

Plastic bag bans rolled back for COVID-19

Regulators are restricting reusable bags over worries they might harbor virus




ed

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease